For instance, Chen et al. reported a marked elevation in ACLY expression at both mRNA and protein levels in breast cancer tissues, with high ACLY levels correlating with worse clinical outcomes and resistance to multiple antitumor drugs [36]. The gene discussed is ACLY; the disease is breast carcinoma.